Attila Zalatnai Selected Research

Attila Zalatnai Research Topics

Disease

21	Neoplasms (Cancer) 07/2020 - 09/2003
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015 - 09/2003
3	Adenocarcinoma 07/2020 - 01/2005
3	Carcinoma (Carcinomatosis) 08/2014 - 01/2005
2	Lymphoma (Lymphomas) 01/2015 - 02/2012
2	Glucagonoma 08/2011 - 01/2009
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Papillomavirus Infections 01/2021
1	Mouth Neoplasms (Oral Cancer) 01/2021
1	Carcinogenesis 01/2021
1	Hyperthermia 07/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2019
1	Hyperglycemia 01/2015
1	Insulinoma 08/2014
1	Breast Neoplasms (Breast Cancer) 07/2012
1	Prostatic Neoplasms (Prostate Cancer) 07/2012
1	Leukemia 07/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2012
1	Lung Neoplasms (Lung Cancer) 02/2012
1	Necrolytic Migratory Erythema 08/2011
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 12/2010
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2010
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 12/2010
1	Pheochromocytoma 12/2010
1	Adrenocortical Adenoma (Disease, Conn's) 10/2010
1	Adenoma (Adenomas) 10/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2010
1	Vipoma (WDHA) 07/2010
1	Dehydration (Water Stress) 07/2010
1	Hyperplasia 01/2009
1	Multiple Endocrine Neoplasia Type 1 01/2009
1	Neuroendocrine Carcinoma 12/2008
1	Primary Immunodeficiency Diseases 12/2008
1	Fibrosis (Cirrhosis) 11/2006
1	Hepatocellular Carcinoma (Hepatoma) 11/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2006
1	Inflammation (Inflammations) 01/2006

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 07/2012 - 03/2007
2	Chromogranin AIBA 04/2019 - 08/2014
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2019 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2005
2	Messenger RNA (mRNA)IBA 01/2015 - 10/2010
2	Glucagon (Glukagon)FDA Link 08/2011 - 01/2009
2	ParaffinIBA 12/2010 - 12/2009
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2010 - 12/2009
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2006 - 01/2005
2	Amino Acids FDA Link 01/2005 - 09/2003
2	MimosineIBA 01/2005 - 09/2003
2	Antineoplastic Agents (Antineoplastics)IBA 01/2005 - 01/2005
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SmokeIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 07/2020
1	Annexin A5IBA 07/2020
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2015
1	Conditioned Culture MediaIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	EcdysteroidsIBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	LigandsIBA 01/2015
1	Ecdysterone (20 Hydroxyecdysone)IBA 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Hormones (Hormone)IBA 08/2014
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 08/2014
1	1,3- dimethyl- 1,3- bis(4- fluorophenyl)- 1,3- bis(3- (1- (4- butypiperazinyl))propyl)disiloxaneIBA 07/2012
1	capsanthinIBA 02/2012
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2012
1	Carotenoids (Carotene)IBA 02/2012
1	XanthophyllsIBA 02/2012
1	capsorubinIBA 02/2012
1	Formaldehyde (Formol)FDA Link 12/2010
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2010
1	MicroRNAs (MicroRNA)IBA 12/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2010
1	glucocorticoid receptor alphaIBA 10/2010
1	Protein Isoforms (Isoforms)IBA 10/2010
1	glucocorticoid receptor betaIBA 10/2010
1	ElectrolytesIBA 07/2010
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2010
1	AcidsIBA 07/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2009
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 08/2009
1	Fluorouracil (Carac)FDA LinkGeneric 08/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2009
1	CD40 Ligand (CD40L)IBA 12/2008
1	Immunoglobulin M (IgM)IBA 12/2008
1	Silicon CompoundsIBA 03/2008
1	1,3- dimethyl- 1,3- (4- fluorophenyl)- 1,3- (3- butyl- (1- piperazinyl)propyl)- 1,3- disiloxaneIBA 03/2008
1	1,3- dimethyl- 1,3- p- fluorophenyl- 1,3- (3- morpholinopropyl)- 1,3- disiloxaneIBA 03/2008
1	AgrinIBA 11/2006
1	IntegrinsIBA 11/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2006
1	CollagenIBA 01/2006

Therapy/Procedure

2	Therapeutics 07/2020 - 01/2005
2	Radiotherapy 07/2020 - 01/2005
2	Drug Therapy (Chemotherapy) 07/2010 - 01/2006